Prevalence and etiology of onychomycosis in patients with psoriasis: a single-center study

Abstract

BACKGROUND: Changes in nails with psoriasis are observed in 80–90% of patients. Pathological processes in the nail apparatus in patients with psoriasis are associated with both the underlying disease and the infectious nature.

AIMS: To evaluate the clinical features of the affected nail plates in patients with psoriasis, the prevalence and etiology of onychomycosis in patients with psoriasis with altered nail plates.

MATERIALS AND METHODS: 102 patients with psoriasis vulgaris, mild and moderate, stationary stage with altered nail plates were examined. A clinical and laboratory (microscopic and cultural) study of the affected nail plates was carried out.

RESULTS: After mycological studies and physical examination of the affected nails of 102 patients, the following groups of nail diseases in patients with psoriasis were identified: psoriatic onychodystrophy (76; 74.5%) patients, onychomycosis (30; 29.4%) patients, traumatic onycholysis (4; 3,9%) patient, onychocryptosis (3; 2.9%) patients. 11 (14.5%) patients with psoriatic onychodystrophy had a complication in the form of a fungal infection. Distal-lateral subungual form of onychomycosis was detected in 17 patients (56.7%), total dystrophic form ― in 10 patients (33.3%), white superficial form ― in 2 patients (6.6%), proximal subungual form ― in 1 patient (3.3%).

CONCLUSIONS: According to the results of clinical and mycological examination of the affected nails of patients with psoriasis, it was revealed that 74.5% of patients have manifestations of psoriatic onychodystrophy, 29.4% ― onychomycosis. Among patients with psoriatic onychodystrophy, 14.5% had a complication in the form of a secondary fungal infection. The main causative agents of onychomycosis are Candida spp. (63.3%). The incidence of dermatophytes (Trichophyton spp.) Was 36.7% of the total number of cases. The main clinical forms of onychomycosis in patients with psoriasis are distal-lateral (56.6%), total dystrophic (33.3%).

Keywords

onychomycosis / psoriasis / psoriatic onychodystrophy

References

[1] Suskova VS, Pinson IYa, Olisova OYu. Immunopathological mechanisms of psoriasis. Russian Journal of Clinical Dermatology and Venereology. 2006;4(1):68-70. (in Russ)

[2] Сускова В.С., Пинсон И.Я., Олисова О.Ю. Иммунопатогенез псориаза. Клиническая дерматология и венерология. 2006. Т. 4, № 1. С. 68-70

[3] Olisova OYu. Teplyuk NP, Pinegin VB. Modern methodes of psoriasis treatment. Russian Journal of Medicine. 2015;(9):483-6. (in Russ)

[4] Олисова О.Ю., Теплюк Н.П., Пинегин В.Б. Современные методы лечения псориаза. РМЖ. 2015. Т. 23, № 9. С. 483-484.

[5] Pasch MC. Nail psoriasis: a review of treatment options. Drugs. 2016;76(6):675–705. doi: 10.1007/s40265-016-0564-5

[6] Pasch M.C. Nail psoriasis: a review of treatment options // Drugs. 2016. Vol. 76, N 6. Р. 675–705. doi: 10.1007/s40265-016-0564-5

[7] Salomon J, Szepietowski JC, Proniewicz A. Psoriatic nails: a prospective clinical study. J Cutan Med Surg. 2003;7(4):317–321. doi: 10.1007/s10227-002-0143-0

[8] Salomon J., Szepietowski J.C., Proniewicz A. Psoriatic nails: a prospective clinical study // J Cutan Med Surg. 2003. Vol. 7, N 4. Р. 317–321. doi: 10.1007/s10227-002-0143-0

[9] Sviridova KV. Features of diagnosis and treatment of onychomycosis in psoriasis [dissertation abstract]. Saint Petersburg; 2009. 20 р. (In Russ).

[10] Свиридова К.В. Особенности диагностики и лечения онихомикоза при псориазе: Автореф. дис. … канд. мед. наук. Санкт-Петербург, 2009. 20 с.

[11] Trevisan F, Werner B, Pinheiro RL. Nail clipping in onychomycosis and comparison with normal nails and ungual psoriasis. An Bras Dermatol. 2019;94(3):344–347. doi: 10.1590/abd1806-4841.20198301

[12] Trevisan F., Werner B., Pinheiro R.L. Nail clipping in onychomycosis and comparison with normal nails and ungual psoriasis // An Bras Dermatol. 2019. Vol. 94, N 3. Р. 344–347. doi: 10.1590/abd1806-4841.20198301

[13] Klaassen KM, Dulak MG, Van de Kerkhof PC, Pasch MC. The prevalence of onychomycosis in psoriatic patients: a systematic review. J Eur Acad Dermatol Venereol. 2014;28(5):533–541. doi: 10.1111/jdv.12239

[14] Klaassen K.M., Dulak M.G., Van de Kerkhof P.C., Pasch M.C. The prevalence of onychomycosis in psoriatic patients: A systematic review // J Eur Acad Dermatol Venereol. 2014. Vol. 28, N 5. Р. 533–541. doi: 10.1111/jdv.12239

[15] Tsentemeidou A, Vyzantiadis TA, Kyriakou A, et al. Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study. Mycoses. 2017;60(12):830–835. doi: 10.1111/myc.12681

[16] Tsentemeidou A., Vyzantiadis T.A., Kyriakou A., et al. Prevalence of onychomycosis among patients with nail psoriasis who are not receiving immunosuppressive agents: Results of a pilot study // Mycoses. 2017. Vol. 60, N 12. Р. 830–835. doi: 10.1111/myc.12681

[17] Kacar N, Ergin S, Ergin C, et al. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial. Clin Exp Dermatol. 2007;32(1):1–5. doi: 10.1111/j.1365-2230.2006.02215.x

[18] Kacar N., Ergin S., Ergin C., et al. The prevalence, aetiological agents and therapy of onychomycosis in patients with psoriasis: a prospective controlled trial // Clin Exp Dermatol. 2007. Vol. 32, N 1. Р. 1–5. doi: 10.1111/j.1365-2230.2006.02215.x

[19] Leibovici V, Hershko K, Ingber A, et al. Increased prevalence of onychomycosis among psoriatic patients in Israel. Acta Derm Venereol. 2008;88(1):31–33. doi: 10.2340/00015555-0323

[20] Leibovici V., Hershko K., Ingber A., et al. Increased prevalence of onychomycosis among psoriatic patients in Israel // Acta Derm Venereol. 2008. Vol. 88, N 1. Р. 31–33. doi: 10.2340/00015555-0323

[21] Zisova L, Valtchev V, Sotiriou E, et al. Onychomycosis in patients with psoriasis ― a multicentre study. Mycoses. 2012;55(2):143–147. doi: 10.1111/j.1439-0507.2011.02053.x

[22] Zisova L., Valtchev V., Sotiriou E., et al. Onychomycosis in patients with psoriasis ― a multicentre study // Mycoses. 2012. Vol. 55, N 2. Р. 143–147. doi: 10.1111/j.1439-0507.2011.02053.x

[23] Stander H, Stander M, Nolting A. [Incidence of fungal involvement in nail psoriasis. (In German)]. Hautarzt. 2001;52(5):418–422. doi: 10.1007/s001050051335

[24] Stander H., Stander M., Nolting A. [Incidence of fungal involvement in nail psoriasis. (In German)] // Hautarzt. 2001. Vol. 52, N 5. Р. 418–422. doi: 10.1007/s001050051335

[25] Rybin AV, Nesterov AS, Potaturkina-Nesterova NI, Nesterova AV. Etiological structure of onychomycosis in patients with psoriasis. Successes of Modern Natural Science. Russian Journal. 2011;(1):107–108. (In Russ).

[26] Рыбин А.В., Нестеров А.С., Потатуркина-Нестерова Н.И., Нестерова А.В. Этиологическая структура онихомикозов у больных псориазом // Успехи современного естествознания. 2011. № 1. С. 107–108.

[27] Rigopoulos D, Papanagiotou V, Daniel R, Piraccini B.M. Onychomycosis in patients with nail psoriasis: a point to point discussion. Mycoses. 2017;60(1):6–10. doi: 10.1111/myc.12542

[28] Rigopoulos D., Papanagiotou V., Daniel R., Piraccini B.M. Onychomycosis in patients with nail psoriasis: a point to point discussion // Mycoses. 2017. Vol. 60, N 1. Р. 6–10. doi: 10.1111/myc.12542

[29] Ventura A, Mazzeo M, Gaziano R, et al. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies. Drug Des Devel Ther. 2017;11:2527–2535. doi: 10.2147/DDDT.S136986

[30] Ventura A., Mazzeo M., Gaziano R., et al. New insight into the pathogenesis of nail psoriasis and overview of treatment strategies // Drug Des Devel Ther. 2017. Vol. 11. Р. 2527–2535. doi: 10.2147/DDDT.S136986

[31] Santiago K, Bomfim GF, Criado PR, Almeida SR. Monocyte-Derived dendritic cells from patients with dermatophytosis restrict the growth of trichophyton rubrum and induce CD4-T cell activation. PLoS One. 2014;9(11):e110879. doi: 10.1371/journal.pone.0110879

[32] Santiago K., Bomfim G.F., Criado P.R., Almeida S.R. Monocyte-Derived dendritic cells from patients with dermatophytosis restrict the growth of trichophyton rubrum and induce CD4-T cell activation // PLoS One. 2014. Vol. 9, N 11. Р. e110879. doi: 10.1371/journal.pone.011087

RIGHTS & PERMISSIONS

Eco-Vector